Clinical Trials Logo

Partial Onset Seizures clinical trials

View clinical trials related to Partial Onset Seizures.

Filter by:

NCT ID: NCT00655551 Completed - Clinical trials for Partial Onset Seizures

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of the trial is to evaluate the safety of intravenous (iv) lacosamide delivered in a single dose followed by 6.5 days of oral lacosamide treatment in subjects with partial-onset seizures.

NCT ID: NCT00655486 Completed - Clinical trials for Partial Onset Seizures

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to allow eligible subjects from the parent study, SP925 [NCT00655551] to continue lacosamide and to obtain additional long-term safety data

NCT ID: NCT00235755 Completed - Clinical trials for Partial-Onset Seizures

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

RESTORE2
Start date: December 2005
Phase: Phase 3
Study type: Interventional

This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 900 mg/day and 600 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).

NCT ID: NCT00232596 Completed - Clinical trials for Partial-Onset Seizures

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

RESTORE1
Start date: September 2005
Phase: Phase 3
Study type: Interventional

This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).